Isolation of oligostilbenes from Iris lactea Pall. var. chinensis (Fisch.) Koidz and their anti-inflammatory activities

Fang-Fang Tie,Yang-Yang Fu,Na Hu,Zhi Chen,Hong-Lun Wang
DOI: https://doi.org/10.1039/d2ra05176a
IF: 4.036
2022-11-17
RSC Advances
Abstract:Iris lactea Pall. var. chinensis (Fisch.) Koidz ( Iris lactea ) is an herbaceous perennial widely distributed in China, India, and South Korea. Iris lactea has been extensively used in traditional Chinese medicine. The present study isolated a new oligostilbene (compound 1 ), together with three known oligostilbenes (compounds 2 , 3 and 4 ) from the seeds of Iris lactea. The structures of these compounds were elucidated by HRESIMS, NMR, and chemical analyses. The network-based pharmacologic analysis platform was used to predict the target proteins related to inflammation of isolated compounds. Furthermore, the isolated compounds were tested for their anti-inflammatory effects in LPS-stimulated RAW 264.7 cells. In this network, 138 candidate targets of compounds related to its therapeutic effect on inflammation were identified. In addition, compounds 1 , 2 , 3 and 4 significantly decreased NO content and the IL-6 levels as well as the expression of COX-2 in LPS-stimulated RAW 264.7 cells.
chemistry, multidisciplinary
What problem does this paper attempt to address?